Market Cap (In INR)
268.7 Million
Revenue (In INR)
97.22 Million
Net Income (In INR)
-23.15 Million
Avg. Volume
2250.00
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 42.57-190.5
- PE
- -
- EPS
- -
- Beta Value
- 0.8013219
- ISIN
- INE695X01011
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dopesh Raja Mulakala
- Employee Count
- -
- Website
- http://www.vantabio.com
- Ipo Date
- 2017-10-06
- Details
- Vanta Bioscience Ltd. engages in the full service preclinical contract research organization. Its services include Discovery Toxicology, Agro-Chemicals and Chemical Safety, Biocompatibility Studies, Diet Formulation and Batch Release Test. The company was founded on April 29, 2016 and is headquartered in Hyderabad, India.
More Stocks
-
ALMOUMoulinvest SA
ALMOU
-
DEEPAKCHEMDEEPAK CHEMTEX LIMITED
DEEPAKCHEM
-
AKRITAkritas S.A.
AKRIT
-
POPULARESPopular Estate Management Limited
POPULARES
-
CUBEXTUBCubex Tubings Limited
CUBEXTUB
-
ZWELCASTWelcast Steels Limited
ZWELCAST
-
ICDSLTDICDS Limited
ICDSLTD
-
MOGANMOGAN ENERJI
MOGAN